Fortress Biotech Inc
NASDAQ:FBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
U
|
Unisys Corp
F:USY1
|
US |
|
DaVita Inc
NYSE:DVA
|
US |
|
W
|
Walgreens Boots Alliance Inc
DUS:W8A
|
US |
|
F
|
Fiserv Inc
XMUN:FIV
|
US |
|
Shimano Inc
TSE:7309
|
JP |
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
P
|
Prysmian SpA
DUS:AEU
|
IT |
|
Z
|
Zhejiang Expressway Co Ltd
XMUN:ZHJ
|
CN |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
U
|
USANA Health Sciences Inc
XMUN:USJ
|
US |
|
Dentsu Group Inc
TSE:4324
|
JP |
|
N
|
Naturgy Energy Group SA
XMUN:GAN
|
ES |
|
A
|
Aurubis AG
OTC:AIAGF
|
DE |
|
F
|
F5 Inc
XMUN:FFV
|
US |
Wall St Price Targets
FBIO Price Targets Summary
Fortress Biotech Inc
According to Wall Street analysts, the average 1-year price target for FBIO is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FBIO's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for FBIO is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Revenue over the next 2 years is 44%.
What is the Gross Profit forecast for Fortress Biotech Inc?
Projected CAGR
63%
The compound annual growth rate for Gross Profit over the next 2 years is 63%.
